Ashwani K Singal
Overview
Explore the profile of Ashwani K Singal including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
241
Citations
3984
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Patel S, Patel S, Zhang W, Singal A, Cheung R, Wong R
Gastro Hep Adv
. 2025 Mar;
4(4):100609.
PMID: 40026700
Background And Aims: Steatotic liver disease (SLD) is the leading indication for liver transplantation (LT) among U.S. adults. We aim to provide comprehensive updates of LT trends and outcomes among...
2.
3.
Dunn N, Al-Khouri N, Ismail A, Singal A
Clin Transl Gastroenterol
. 2025 Feb;
PMID: 39969015
The term Steatotic Liver Disease is now used to describe conditions involving fat accumulation in the liver. Steatotic Liver Disease term includes a spectrum of defined and less defined disorders;...
4.
Idalsoaga F, Diaz L, Guizzetti L, Dunn W, Mehta H, Arnold J, et al.
Aliment Pharmacol Ther
. 2025 Feb;
PMID: 39967231
Several dynamic models predict mortality and corticosteroid response in alcohol-associated hepatitis (AH), yet no consensus exists on the most effective model. This study aimed to assess predictive models for corticosteroid...
5.
Choudhury A, Kulkarni A, Arora V, Soin A, Dokmeci A, Chowdhury A, et al.
Hepatol Int
. 2025 Feb;
19(1):1-69.
PMID: 39961976
Acute-on-chronic liver failure (ACLF) is a condition associated with high mortality in the absence of liver transplantation. There have been various definitions proposed worldwide. The first consensus report of the...
6.
Singal A, Kuo Y
J Clin Transl Hepatol
. 2025 Jan;
13(1):88-92.
PMID: 39801780
No abstract available.
7.
Singal A, Pannerselvam D, Arab J, Im G, Kuo Y
Am J Gastroenterol
. 2024 Dec;
PMID: 39714037
Introduction: Data are limited regarding etiology-specific trends for delisting and recompensation for liver disease improvement among liver transplantation (LT)-listed candidates in the United States. Methods And Results: A retrospective cohort...
8.
Arab J, Diaz L, Rehm J, Im G, Arrese M, Kamath P, et al.
J Hepatol
. 2024 Nov;
PMID: 39608457
In this position statement, we explore the intricate relationship between alcohol intake and metabolic dysfunction in the context of the 2023 nomenclature update for steatotic liver disease (SLD). Recent and...
9.
Gripshover T, Treves R, Rouchka E, Chariker J, Zheng S, Hudson E, et al.
Alcohol Clin Exp Res (Hoboken)
. 2024 Nov;
49(1):106-116.
PMID: 39592394
Background: Alcohol-associated hepatitis (AH) is the clinical manifestation of alcohol-associated liver disease (ALD). AH is a complex disease encompassing the dysregulation of many cells and cell subpopulations. This study used...
10.
Diaz L, Lazarus J, Fuentes-Lopez E, Idalsoaga F, Ayares G, Desaleng H, et al.
Commun Med (Lond)
. 2024 Oct;
4(1):219.
PMID: 39472739
Introduction: The 2023 nomenclature defined criteria for steatotic liver disease (SLD), including metabolic dysfunction-associated SLD (MASLD), alcohol-associated liver disease (ALD), and the overlapping MASLD/ALD (MetALD). We aimed to assess racial...